168 related articles for article (PubMed ID: 28847478)
1. Pharmacologically Safe Nanomicelles of Amphotericin B With Lipids: Nuclear Magnetic Resonance and Molecular Docking Approach.
Usman F; Ul-Haq Z; Khalil R; Tinpun K; Srichana T
J Pharm Sci; 2017 Dec; 106(12):3574-3582. PubMed ID: 28847478
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier.
Usman F; Khalil R; Ul-Haq Z; Nakpheng T; Srichana T
AAPS PharmSciTech; 2018 Jul; 19(5):2077-2086. PubMed ID: 29691753
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
Usman F; Nopparat J; Javed I; Srichana T
Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
[TBL] [Abstract][Full Text] [Related]
5. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
Alvarez C; Shin DH; Kwon GS
Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
7. Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B.
Serafim C; Ferreira I; Rijo P; Pinheiro L; Faustino C; Calado A; Garcia-Rio L
Int J Pharm; 2016 Jan; 497(1-2):23-35. PubMed ID: 26617315
[TBL] [Abstract][Full Text] [Related]
8. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
Jansook P; Fülöp Z; Ritthidej GC
Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
Nimtrakul P; Tiyaboonchai W; Lamlertthon S
Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S
Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151
[TBL] [Abstract][Full Text] [Related]
11. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
Jain S; Valvi PU; Swarnakar NK; Thanki K
Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
[TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations.
Jansook P; Pichayakorn W; Ritthidej GC
Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of GM1 micelles-Amphotericin B interaction.
Leonhard V; Alasino RV; Bianco ID; Garro AG; Heredia V; Beltramo DM
Curr Drug Deliv; 2015; 12(4):406-14. PubMed ID: 25772153
[TBL] [Abstract][Full Text] [Related]
15. Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier 'sodium deoxycholate sulfate'.
Madhumanchi S; Suedee R; Nakpheng T; Tinpun K; Temboot P; Srichana T
Colloids Surf B Biointerfaces; 2019 Oct; 182():110374. PubMed ID: 31330430
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
17. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
18. Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections.
Rolón M; Serrano DR; Lalatsa A; de Pablo E; Torrado JJ; Ballesteros MP; Healy AM; Vega C; Coronel C; Bolás-Fernández F; Dea-Ayuela MA
Mol Pharm; 2017 Apr; 14(4):1095-1106. PubMed ID: 28198632
[TBL] [Abstract][Full Text] [Related]
19. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
Yu BG; Okano T; Kataoka K; Kwon G
J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
[TBL] [Abstract][Full Text] [Related]
20. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
